InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,973.10
(
0.74%
)
US TECH 100
20,544.40
(
1.59%
)
Dow Jones
43,729.34
(
0.00%
)
Brent Oil
75.05
(
-0.55%
)
Bitcoin
75,856.40
(
-0.06%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Sheep

Send PM Follow Ignore
Followers 114
Posts 6021
Boards Moderated 3
Alias Born 09/16/2009

Sheep

Re: $heff post# 77721

Friday, 02/21/2014 9:01:13 AM

Friday, February 21, 2014 9:01:13 AM

Post# of 97239
$LJPC Phase 2 Completed data in March


“We are pleased to have completed the Phase 2 study dosing and want to thank the patients and investigators who participated,” said George Tidmarsh, MD, PhD, President and CEO at La Jolla. “We look forward to analyzing the data which we expect to release in March.”



La Jolla Pharmaceutical Company Announces Final Dosing in Phase 2 Clinical Trial of GCS-100 in Chronic Kidney Disease
http://finance.yahoo.com/news/la-jolla-pharmaceutical-company-announces-130000137.html

Email: sheepery@gmail.com

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up